Officials with the FDA have approved a label expansion for fluralaner for extended-release injectable suspension (Bravecto ...
Merck’s (MRK) animal health unit announced that the U.S. FDA approved a label expansion for its once-yearly parasiticide treatment Bravecto Quantum to treat two additional tick species in dogs.
The FDA proposes front-of-package "Nutrition Info boxes" to highlight saturated fat, sodium, and added sugars. The initiative aims to combat chronic diseases and promote healthier food choices. Large ...
GSK (GSK) stock is in focus as the U.S. FDA expands authorization for the company's Arexvy RSV vaccine to cover adults 18–49. Read more here.
Pharmaceutical Technology on MSN
GSK’s RSV jab secures FDA label expansion to larger adult population
Arexvy will now compete for market share with Pfizer’s Abrysvo and Moderna’s mRESVIA in this expanded, high-risk adult population.
Sarah Todd returned to reporting in January 2025 after being assignment editor at STAT since October 2022. You can reach Sarah on Signal at sarahlizchar.47. A new government proposal to display ...
WASHINGTON — The Food and Drug Administration said on Monday it is revising the labeling of all extended-release stimulants used to treat attention-deficit hyperactivity disorder to include warnings ...
With President Trump back in the Oval Office and Robert F. Kennedy possibly to follow at the Department of Health and Human Services, it’s hard to say what’s in store for the Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results